LY5
LY5 is a STAT3 inhibitor with an IC50 value of 0.5 μM. LY5 induces apoptosis and inhibits STAT3 phosphorylation. LY5 shows antitumor activity in vivo, it can be used for the research of cancer[1].
Product Specifications
CAS Number
1436382-03-4
UNSPSC
12352005
Target
Apoptosis; STAT
Type
Reference compound
Related Pathways
Apoptosis; JAK/STAT Signaling; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ly5.html
Purity
97.02
Solubility
DMSO : 6.25 mg/mL (ultrasonic)
Smiles
NS(=O)(C1=C2C(C(C(NC3=CC=CN=C3)=CC2=O)=O)=CC=C1)=O
Molecular Formula
C15H11N3O4S
Molecular Weight
329.33
References & Citations
[1]Yu W, et al. Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design. J Med Chem. 2013 Jun 13;56 (11) :4402-12.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
034134-ML550 100 µL
CORO7, NT (CORO7, Coronin-7, 70kD WD repeat tumor rejection antigen homolog) (MaxLight 550) discontinued
Sign In for Pricing
View Details 
MBS2132452-01 0.1 mL
APC_Cy7 Linked Monoclonal Antibody to Cluster Of Differentiation 4 (CD4)
Sign In for Pricing
View Details MBS2132452-02 0.2 mL
APC_Cy7 Linked Monoclonal Antibody to Cluster Of Differentiation 4 (CD4)
Sign In for Pricing
View Details MBS2132452-03 0.5 mL
APC_Cy7 Linked Monoclonal Antibody to Cluster Of Differentiation 4 (CD4)
Sign In for Pricing
View Details